Oaktree Acquisition (OAC) Competitors

Oaktree Acquisition (NYSE:OAC) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment.

Is OAC or LFMD more profitable?

Oaktree Acquisition has a net margin of 0.00% compared to LifeMD's net margin of -14.01%.

Company	Net Margins	Return on Equity	Return on Assets
Oaktree Acquisition	N/A	N/A	N/A
LifeMD	-14.01%	N/A	-50.74%

Does the MarketBeat Community believe in OAC or LFMD?

LifeMD received 20 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 67.65% of users gave LifeMD an outperform vote.

Company	Underperform	Outperform
Oaktree Acquisition	Outperform Votes 3 100.00%	Underperform Votes No Votes
LifeMD	Outperform Votes 23 67.65%	Underperform Votes 11 32.35%

Do insiders & institutionals have more ownership in OAC or LFMD?

47.6% of Oaktree Acquisition shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 18.9% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, OAC or LFMD?

Oaktree Acquisition has a beta of 0.17, meaning that its share price is 83% less volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500.

Does the media prefer OAC or LFMD?

In the previous week, Oaktree Acquisition and Oaktree Acquisition both had 1 articles in the media. LifeMD's average media sentiment score of 1.62 beat Oaktree Acquisition's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oaktree Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts rate OAC or LFMD?

LifeMD has a consensus price target of $10.20, indicating a potential upside of 5.37%. Given LifeMD's higher probable upside, analysts plainly believe LifeMD is more favorable than Oaktree Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oaktree Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
LifeMD	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger valuation & earnings, OAC or LFMD?

Oaktree Acquisition has higher earnings, but lower revenue than LifeMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oaktree Acquisition	N/A	N/A	$1.15M	N/A	N/A
LifeMD	$152.55M	2.57	-$20.60M	-$0.70	-13.86

Summary

LifeMD beats Oaktree Acquisition on 7 of the 12 factors compared between the two stocks.